What is Karolinska Development AB (publ) (KDEVF)?

Karolinska Development AB (publ) (KDEVF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of KDEVF?

The current price of KDEVF is $0.26. Prices are updated in real time on Stocks360.

What is KDEVF's price-to-earnings (PE) ratio?

KDEVF's trailing twelve-month PE ratio is -6.51, based on current price and earnings per share data available on Stocks360.

What is KDEVF's market capitalization?

KDEVF's market capitalization is $68,850,739.00, placing it in the small-cap tier.

Karolinska Development AB (publ) (KDEVF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.26

Market Cap

$68.85M

PE (TTM)

-6.51

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.24

Day Range

$0.26 – $0.26

52-wk Range

$0.26 – $0.61

Avg Volume

N/A

Volume

2.50K

Karolinska Development AB (publ) (KDEVF) is a publicly traded company in the Healthcare sector. Latest price: $0.26. Market cap $68.85M. Trailing PE -6.51. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Karolinska Development AB (publ)

Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets a wide array of life science domains, including pharmaceutical and genetic research and development, medical advancements, healthcare technology, innovative drug delivery systems, biotechnology, and specialized tools and service providers for the life science industry. The company strategically prioritizes investment opportunities within the Nordic region, specifically highlighting Sweden, Iceland, Norway, Finland, and Denmark. While the firm prefers to assume the role of a lead investor in its portfolio enterprises, it also remains open to participating in co-investment ventures. On an annual basis, it endeavors to finance a maximum of five new projects. Karolinska Development AB (publ) was established in 2003 and maintains its headquarters in Stockholm, Sweden.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-6.51×
P/S (TTM)	158.36×
P/B	0.12×
P/FCF (TTM)	-71.11×
EV / EBITDA	-4.10×
EV / Sales	133.72×
Earnings Yield	-105.47%
Free Cash Flow Yield	-1.41%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$570.48M
Revenue (TTM)	$4.27M
Net Income (TTM)	-$712.50M
Free Cash Flow (TTM)	-$9.50M
Net Debt	-$105.10M
Working Capital	$108.97M
Gross Margin	82.57%
Operating Margin	-3281.50%
Net Margin	-3277.04%
Return on Equity	-13.02%
Return on Invested Capital	-12.64%